|
Volumn 4, Issue 3, 2002, Pages 165-168
|
Genetic epidemiology systemic sclerosis
|
Author keywords
Candidate genes; Genetic epidemiology; Scleroderma; Systemic sclerosis
|
Indexed keywords
CHEMOKINE RECEPTOR CXCR2;
COLLAGEN TYPE 1;
FIBRILLIN;
HLA ANTIGEN;
HLA DR1 ANTIGEN;
INTERLEUKIN 8;
INTERLEUKIN 8 RECEPTOR;
PLATELET DERIVED GROWTH FACTOR A;
PLATELET DERIVED GROWTH FACTOR B;
TRANSFORMING GROWTH FACTOR BETA;
TRANSFORMING GROWTH FACTOR BETA RECEPTOR;
TRANSFORMING GROWTH FACTOR BETA1;
TUMOR NECROSIS FACTOR;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ATROPHY;
AUTOIMMUNITY;
COHORT ANALYSIS;
CONNECTIVE TISSUE DISEASE;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
FAMILIAL DISEASE;
FEMALE;
GENE MAPPING;
GENETIC ANALYSIS;
GENETIC CODE;
GENETIC EPIDEMIOLOGY;
GENETIC LINKAGE;
GENETIC PREDISPOSITION;
GENETIC VARIABILITY;
HUMAN;
LUNG FIBROSIS;
MALE;
MOUSE;
NONHUMAN;
PATHOGENESIS;
PHENOTYPE;
REVIEW;
RISK FACTOR;
SINGLE NUCLEOTIDE POLYMORPHISM;
SYSTEMIC SCLEROSIS;
ANIMALS;
AUSTRALIA;
DISEASE MODELS, ANIMAL;
FEMALE;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
INDIANS, NORTH AMERICAN;
LINKAGE (GENETICS);
MALE;
SCLERODERMA, SYSTEMIC;
UNITED STATES;
|
EID: 0036240743
PISSN: 14659905
EISSN: None
Source Type: Journal
DOI: 10.1186/ar402 Document Type: Review |
Times cited : (33)
|
References (29)
|